Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum

By sjmartinez • January 6, 2024

Hoffman RM, Brummel S, Ziemba L, Chinula L, McCarthy K, Fairlie L, Jean-Philippe P, Chakhtoura N, Johnston B, Krotje C, Nematadzira TG, Nakayiwa F, Ndyanabangi V, Hanley S, Theron G, Violari A, João E, Correa Junior MD, Hofer CB, Navanukroh O, Aurpibul L, Nevrekar N, Zash R, Shapiro R, Stringer JSA, Currier JS, Sax P, Lockman S; IMPAACT 2010/VESTED Study Team. Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum. Clin Infect Dis. 2024 Jan 5:ciae001. doi: 10.1093/cid/ciae001. Epub ahead of print. PMID: 38180851.

Tags: adverse pregnancy outcomes, antepartum weight change, HIV, Infectious Diseases, postpartum weight, Publications, Women’s health

Opportunities to Optimize Outcomes of Diagnosis and Treatment of HIV and Syphilis in Pregnancy: the Quest to Eliminate Maternal and Vertical Transmission

Joseph Davey D, de Voux A, Shaetonhodi N, Marks M, Frigati L, Kufa T. Opportunities to Optimize Outcomes of Diagnosis and Treatment of HIV and[...]

Hybrid strategy of coronary atherosclerosis characterization with T1-weighted MRI and CT angiography to noninvasively predict periprocedural myocardial injury

Matsumoto H, Higuchi S, Li D, Tanisawa H, Isodono K, Irie D, Ohya H, Kitamura R, Kaneko K, Nakazawa M, Suzuki K, Komori Y, Hondera[...]

Repercussions of the COVID- 19 pandemic on maternal and congenital syphilis in South Brazil: a time series analysis 2010-2022

Echegaray F, Hernandez CJ, Sundar KG, Yang LZ, Cambou MC, Segura ER, de Melo MG, Santos BR, Dos Santos Varella IR, Nielsen-Saines K. Repercussions of[...]